BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10379972)

  • 21. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
    Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
    Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.
    Advani SM; Advani PG; VonVille HM; Jafri SH
    BMC Cancer; 2018 Nov; 18(1):1174. PubMed ID: 30482179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models for nutrition in cancer.
    Baracos VE; Le Bricon T
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():167-80; discussion 180-2. PubMed ID: 11490572
    [No Abstract]   [Full Text] [Related]  

  • 24. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Graf SA; Garcia JM
    Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel approaches to the treatment of cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Drug Discov Today; 2008 Jan; 13(1-2):73-8. PubMed ID: 18190867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new horizon of herbal medicines in anorexia-cachexia syndrome.
    Inui A
    Curr Pharm Des; 2012; 18(31):4747-8. PubMed ID: 22950447
    [No Abstract]   [Full Text] [Related]  

  • 28. Skeletal muscle anabolism in patients with advanced cancer.
    Baracos VE
    Lancet Oncol; 2015 Jan; 16(1):13-4. PubMed ID: 25524803
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of the drug treatment of cachexia associated with cancer.
    Gagnon B; Bruera E
    Drugs; 1998 May; 55(5):675-88. PubMed ID: 9585863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cachexia, the metabolic component of neoplastic diseases.
    Costa G
    Cancer Res; 1977 Jul; 37(7 Pt 2):2327-35. PubMed ID: 324611
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic abnormalities in cancer patients: carbohydrate metabolism.
    Chlebowski RT; Heber D
    Surg Clin North Am; 1986 Oct; 66(5):957-68. PubMed ID: 3532381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms and treatment of cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23 Suppl 1():S19-24. PubMed ID: 22749678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does cachexia prevention improve outcome of chronic disease and cancer?
    Biolo G; Guadagni M; Ciocchi B
    Intern Emerg Med; 2011 Apr; 6(2):101-3. PubMed ID: 21347862
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer cachexia: a therapeutic approach.
    Argilés JM; Meijsing SH; Pallarés-Trujillo J; Guirao X; López-Soriano FJ
    Med Res Rev; 2001 Jan; 21(1):83-101. PubMed ID: 11135301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review.
    Balstad TR; Solheim TS; Strasser F; Kaasa S; Bye A
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):210-21. PubMed ID: 24703549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.
    Chlebowski RT; Heber D; Richardson B; Block JB
    Cancer Res; 1984 Feb; 44(2):857-61. PubMed ID: 6692384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory therapies in cancer cachexia.
    Argilés JM; Busquets S; López-Soriano FJ
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S81-6. PubMed ID: 21835173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EORTC-NCI-AACR--20th symposium molecular targets and cancer therapeutics.
    Din S
    IDrugs; 2008 Dec; 11(12):855-6. PubMed ID: 19051141
    [No Abstract]   [Full Text] [Related]  

  • 40. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.